The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. As management looks to ...

Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results Business Wire Jun 26, 2025, 11:00:00 AM. Walgreens and KFF’s Greater Than Campaign to Offer Free HIV/STD Testing in Stores ...

The Walgreens Boots Alliance-owned UK retailer’s online revenue grew 17% thanks to a demand for beauty and wellness products ...

In March, the two agreed to a $10 billion deal that will see Sycamore take Walgreens private, ending nearly a century of public trading. The transaction is anticipated to close in the third or fourth ...

Walgreens' third quarter sales increased 7.2% year-over-year to $39 billion, up 6.9% on a constant currency basis.

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.

Analysts expect Walgreens Boots Alliance to report an earnings per share (EPS) of $0.34. Investors in Walgreens Boots Alliance are eagerly awaiting the company's announcement, hoping for news of ...

Review the current Walgreens Boots Alliance Inc (WBA:XNAS) dividend yield and history to decide if WBA is the best investment for you.